Showing results (1021-1030 of 1,907) with videos related to

Sort By:
Pageof 191
JAMA|January 24, 2008
Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertensionAmy I Lynch, Eric Boerwinkle, Barry R Davis, et al.
Annals of Human Genetics|July 5, 2007
Sex-specific effects of AGT-6 and ACE I/D on pulse pressure after 6 months on antihypertensive treatment: the GenHAT studyA I Lynch, D K Arnett, B R Davis, et al.
Endocrinology|September 19, 2006
Overlapping and distinct expression of progesterone receptors A and B in mouse uterus and mammary gland during the estrous cyclePatricia A Mote, Rebecca L Arnett-Mansfield, Natalie Gava, et al.
Cardiovascular Ultrasound|November 10, 2006
Diabetes, gender, and left ventricular structure in African-Americans: the atherosclerosis risk in communities studyMurilo Foppa, Bruce B Duncan, Donna K Arnett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2013
The pore-forming toxin listeriolysin O is degraded by neutrophil metalloproteinase-8 and fails to mediate Listeria monocytogenes intracellular survival in neutrophilsEusondia Arnett, Stephen Vadia, Colleen C Nackerman, et al.
Hypertension (Dallas, Tex. : 1979)|March 7, 2007
Genetic variations associated with echocardiographic left ventricular traits in hypertensive blacksKristin J Meyers, Thomas H Mosley, Ervin Fox, et al.
Pharmacogenetics and Genomics|April 9, 2009
Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT studyAmy I Lynch, Eric Boerwinkle, Barry R Davis, et al.
Annals of Internal Medicine|September 1, 1979
Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findingsE N Arnett, J M Isner, D R Redwood, et al.
Nutrition & Metabolism|December 25, 2007
Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?Aldi T Kraja, Michael A Province, Donna Arnett, et al.
Neurogastroenterology and Motility|September 30, 2024
FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF1 agonist mediated visceral hypersensitivity in male ratsMuriel Larauche, Agata Mulak, Chrysanthy Ha, et al.
Pageof 191